Cas 1383718-61-3,(rac)-3-fluoro-4-((7-methyl-5-oxo-5,6,7,8-tetrahydroquinazolin-2-yl)amino)benzonitrile

1383718-61-3

Post Buying Request

Basic information

Product Name: (rac)-3-fluoro-4-((7-methyl-5-oxo-5,6,7,8-tetrahydroquinazolin-2-yl)amino)benzonitrile
Synonyms: (rac)-3-fluoro-4-((7-methyl-5-oxo-5,6,7,8-tetrahydroquinazolin-2-yl)amino)benzonitrile
CAS NO:1383718-61-3
Molecular Formula:
Molecular Weight: 296.304
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (rac)-3-fluoro-4-((7-methyl-5-oxo-5,6,7,8-tetrahydroquinazolin-2-yl)amino)benzonitrile(CAS DataBase Reference)
NIST Chemistry Reference: (rac)-3-fluoro-4-((7-methyl-5-oxo-5,6,7,8-tetrahydroquinazolin-2-yl)amino)benzonitrile(1383718-61-3)
EPA Substance Registry System: (rac)-3-fluoro-4-((7-methyl-5-oxo-5,6,7,8-tetrahydroquinazolin-2-yl)amino)benzonitrile(1383718-61-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1383718-61-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1383718-61-3 Suppliers

Recommended suppliers

1383718-61-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1383718-61-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,3,7,1 and 8 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1383718-61:
(9*1)+(8*3)+(7*8)+(6*3)+(5*7)+(4*1)+(3*8)+(2*6)+(1*1)=183
183 % 10 = 3
So 1383718-61-3 is a valid CAS Registry Number.

1383718-61-3Upstream product

1383718-61-3Downstream Products

1383718-61-3Relevant academic research and scientific papers

METABOTROPIC GLUTAMATE RECEPTOR MODULATORS

-

Page/Page column 55-56, (2012/07/13)

The invention relates to heterocyclic derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorder

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1383718-61-3